Thank you. While I usually do take The Economist at face value, I don't believe that was accurate at all. I do believe that we are on track for the end of September or I wouldn't be saying so repeatedly. I believe that we will have enough vaccines to vaccinate all Canadians by the end of September based on approved vaccines alone. As soon as additional vaccines come online—for example, we have AstraZeneca and J&J in regulatory review—we will have additional vaccines for Canadians.
Once again, this is an example of our diversified procurement approach so that we will have multiple options for vaccines on the table for Canadians. Professor Susan Athey from Stanford University and many others have lauded Canada's vaccine procurement approach as being one that is excellent. Indeed, the CEO of Novavax himself has said that Canada has it right on procurement.